<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04488341</url>
  </required_header>
  <id_info>
    <org_study_id>P.T.REC/012/002676</org_study_id>
    <nct_id>NCT04488341</nct_id>
  </id_info>
  <brief_title>Effect of Aerobic Exercises on Sex Hormones and Coagulation Factors in Postmenopausal Elderly Women</brief_title>
  <official_title>Effect of Aerobic Exercises on Sex Hormones and Coagulation Factors in Postmenopausal Elderly Women</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Cairo University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Cairo University</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      PURPOSE:&#xD;
&#xD;
      to determine the effect of aerobic exercise training on sex hormones and coagulation factors&#xD;
      in postmenopausal elderly women&#xD;
&#xD;
      BACKGROUND:&#xD;
&#xD;
      Cardiovascular disease (CVD) is the largest cause of death in women, and the risk of&#xD;
      developing CVD increases after menopause . Because thrombosis is thought to be a cause of&#xD;
      most acute cardiovascular events, abnormalities in endogenous coagulation and fibrinolysis&#xD;
      may play an important role in the risk of an acute cardiovascular event. Aging is also&#xD;
      associated with adverse changes in both coagulation and fibrinolysis. For instance,&#xD;
      postmenopausal women exhibit higher fibrinogen levels and lower levels of endogenous&#xD;
      fibrinolysis. Physical activity and physical fitness have consistently been linked to lower&#xD;
      CVD rates in women. In fact, an inverse association between physical activity and total&#xD;
      mortality, as well as a 50% reduction in risk of myocardial infarction, has been observed in&#xD;
      physically active postmenopausal women. In addition to the numerous other benefits provided&#xD;
      by regular physical activity, one of the mechanisms mediating the cardioprotective effect may&#xD;
      be changes in the hemostatic system, particularly fibrinolysis&#xD;
&#xD;
      HYPOTHESES:&#xD;
&#xD;
      Aerobic exercises may have no effect on sex hormones and coagulation factors in elderly&#xD;
      postmenopausal women&#xD;
&#xD;
      RESEARCH QUESTION:&#xD;
&#xD;
      Do aerobic exercises effect on sex hormones and coagulation factors in elderly postmenopausal&#xD;
      women in response to exercises?&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      It is an interventional study in which 40 women estimated to enroll according to random&#xD;
      allocation and assigned into two groups equally. The study group will receive aerobic&#xD;
      exercises in addition to diet recommendations while the control group will receive diet&#xD;
      recommendations. the aerobic exercises time of session 40-50 min initial 10 min warm up&#xD;
      exercises on treadmill in low intensity and active phase 20- 30 min intensity will increase&#xD;
      until patient reach to target heart rate then intensity decrease until session will be ended&#xD;
      by cooling down phase for 10 min . The volunteers will perform exercises 3 times per week for&#xD;
      12 weeks .coagulation factors(Prothrombin time, Partial Thromboplastin Time , plasminogen&#xD;
      activator inhibitor-1 , fibrinogen and tissue plasminogen activator )will be measured and sex&#xD;
      hormones (estradiol ,testosterone. sex hormone binding globin ) pre and post intervention&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">September 20, 2020</start_date>
  <completion_date type="Anticipated">August 20, 2022</completion_date>
  <primary_completion_date type="Anticipated">May 15, 2022</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>coagulation factors</measure>
    <time_frame>12 weeks</time_frame>
    <description>change of selected coagulation factors by blood analysis (plasminogen activator inhibitor-1 ,tissue plasminogen activator ,Prothrombin time ,Partial Thromboplastin time ,fibrinogen )</description>
  </primary_outcome>
  <primary_outcome>
    <measure>sex hormones</measure>
    <time_frame>12 weeks</time_frame>
    <description>change of (estradiol ,testosterone. sex hormone binding globin )</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>weight</measure>
    <time_frame>12 weeks</time_frame>
    <description>measuring weight in kilograms</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>height</measure>
    <time_frame>12 weeks</time_frame>
    <description>measuring height in meters</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">40</enrollment>
  <condition>Coagulation Disorder</condition>
  <arm_group>
    <arm_group_label>aerobic exercises in addition to diet</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>The study group will receive aerobic exercises in addition to diet recommendations</description>
  </arm_group>
  <arm_group>
    <arm_group_label>diet recommendations</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>control group will receive diet recommendations</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>aerobic exercises in addition to diet recommendations</intervention_name>
    <description>aerobic exercises time of session 40-50 min initial 10 min warm up exercises on treadmill in low intensity and active phase 20- 30 min intensity will increase until patient reach to target heart rate then intensity decrease until session will be ended by cooling down phase for 10 min . The volunteers will perform exercises 3 times per week for 12 weeks</description>
    <arm_group_label>aerobic exercises in addition to diet</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>diet recommendations</intervention_name>
    <description>control group will receive diet recommendations for 12 weeks</description>
    <arm_group_label>aerobic exercises in addition to diet</arm_group_label>
    <arm_group_label>diet recommendations</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  • forty Postmenopausal women (60-70 y)&#xD;
&#xD;
               -  Body mass index (BMI) ranged from 35 to 39.9 kg/m2&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  • regular medications(e.g., β-blockers, α-blockers, digoxin, diuretics, aspirin,&#xD;
             nitrates, Presently using hormone replacement therapy (HRT) and non steroidal&#xD;
             anti-inflammatory drugs,&#xD;
&#xD;
               -  smoking;&#xD;
&#xD;
               -  cognitive impairment that will make it difficult to partake in the study&#xD;
&#xD;
               -  presence of malignant disease&#xD;
&#xD;
               -  blood donation within the last 6 months&#xD;
&#xD;
               -  Participation as a subject in any type of study or research during the prior 90&#xD;
                  days&#xD;
&#xD;
               -  hypertension,&#xD;
&#xD;
               -  having active chronic illness (e.g., rheumatoid arthritis, hyperthyroidism, and&#xD;
                  inflammatory bowel disease) and diabetes mellitus or other (unstable)&#xD;
                  endocrine-related diseases&#xD;
&#xD;
               -  personal history of cardiovascular diseases,&#xD;
&#xD;
               -  Orthopedic problems inhibiting exercises.&#xD;
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>60 Years</minimum_age>
    <maximum_age>70 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>hany fm elsisi, phd</last_name>
    <role>Principal Investigator</role>
    <affiliation>physical therapy faculty Cairo university</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Hany FM Elsisi, phd</last_name>
    <phone>00966580239275</phone>
    <phone_ext>966</phone_ext>
    <email>Elsisihany309@gmail.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Physical Therapy</name>
      <address>
        <city>Cairo</city>
        <zip>11432</zip>
        <country>Egypt</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>hany fm elsisi, Phd</last_name>
      <phone>00966580239275</phone>
      <phone_ext>966</phone_ext>
      <email>Elsisihany309@gmail.com</email>
    </contact>
  </location>
  <location_countries>
    <country>Egypt</country>
  </location_countries>
  <verification_date>August 2021</verification_date>
  <study_first_submitted>July 14, 2020</study_first_submitted>
  <study_first_submitted_qc>July 22, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">July 28, 2020</study_first_posted>
  <last_update_submitted>August 9, 2021</last_update_submitted>
  <last_update_submitted_qc>August 9, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">August 11, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Cairo University</investigator_affiliation>
    <investigator_full_name>Hany Farid Eid morsy Elsisi</investigator_full_name>
    <investigator_title>principal investigator</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hemostatic Disorders</mesh_term>
    <mesh_term>Blood Coagulation Disorders</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Yes</sharing_ipd>
    <ipd_description>all IPD that underlie results in a publication</ipd_description>
    <ipd_info_type>Study Protocol</ipd_info_type>
    <ipd_time_frame>2 years after completion study</ipd_time_frame>
    <ipd_access_criteria>journal publishes the study</ipd_access_criteria>
    <ipd_url>http://Scholar.cu.edu.eg/p_t</ipd_url>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

